Send feedback

HAL p.Thr229Ile

c.686C>T · rs143844261 · VCV310717

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.2665 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0329%, mid)
Missense predictors
1/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
histidinemia

Computational evidence

Protein change
AlphaMissense0.2665likely benign
REVEL0.673pathogenic-leaning
SaProtLLR -7.98tolerated
⇒ REVEL calls this damaging; AlphaMissense and SaProt do not.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12GERP 1.2, phastCons 1
Regional constrainto/e 0.95unconstrained · MANE · 22 kb · p 0.18 · regional, not allelic
Overall
CADD24.3PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0329% Middle Eastern · 2/6,078 alleles
Filtering AF 0.0266% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0256%
Overall 0.0288% 464/1,612,638 alleles · ultra-rare exomes 412/1,460,458 · genomes 52/152,180 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.26% 384
Middle Easterngrpmax 0.0329% 3,039
Remaining individualsnot grpmax-eligible 0.032% 3,121
European (non-Finnish) 0.0292% 3,427
Admixed American 0.015% 6,666
Finnishnot grpmax-eligible 0.00937% 10,668
African / African-American 0.00534% 18,723
South Asian 0.0022% 45,533

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
HAL
Protein
p.Thr229Ile
Coding
c.686C>T
MANE Select
NM_002108
dbSNP
rs143844261
Type
single nucleotide variant
Location
chr12:95992709 (GRCh38)
Gene constraint
LOEUF 1.213 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 90.83
Full HAL gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

histidinemia — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Histidinemia (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy, Neonatal
Prevalence
1-9 / 100 000 (Sweden)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/hal-p-thr229ile (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown